Skin cancer: Difference between revisions
Jump to navigation
Jump to search
Line 31: | Line 31: | ||
==Treatment== | ==Treatment== | ||
[[Skin cancer medical therapy|Medical Therapy]] | [[Skin cancer surgery|Surgery]] | [[Skin cancer primary prevention|Primary Prevention]] | [[Skin cancer secondary prevention|Secondary Prevention]] | [[Skin cancer cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Skin cancer future or investigational therapies|Future or Investigational Therapies]] | |||
[[Skin cancer primary prevention|Primary Prevention]] | [[Skin cancer secondary prevention|Secondary Prevention]] | [[Skin cancer cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Skin cancer future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | ==Case Studies== | ||
[[Skin cancer case study one|Case #1]] | [[Skin cancer case study one|Case #1]] |
Revision as of 18:12, 17 September 2012
Skin cancer Microchapters |
Skin cancer | |
ICD-10 | C43-C44 |
---|---|
ICD-9 | 172, 173 |
ICD-O: | 8010-8720 |
MeSH | D012878 |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Skin cancer from other Disorders
Epidemiology & Demographics
Risk factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Tests | Biopsy | Chest X Ray | MRI | CT | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies